{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:53:31Z","timestamp":1790438011060,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":691,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 HL086559"],"award-info":[{"award-number":["R01 HL086559"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["PO1 HL0888093"],"award-info":[{"award-number":["PO1 HL0888093"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 HL087391"],"award-info":[{"award-number":["R01 HL087391"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AHA Scientist Development Awards"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.jacc.2011.07.017","type":"journal-article","created":{"date-parts":[[2011,10,9]],"date-time":"2011-10-09T08:05:23Z","timestamp":1318147523000},"page":"1715-1727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"title":["Human Oxidation-Specific Antibodies Reduce Foam Cell Formation and Atherosclerosis Progression"],"prefix":"10.1016","volume":"58","author":[{"given":"Sotirios","family":"Tsimikas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Miyanohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Hartvigsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Merki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter X.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Yun","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Pattison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Torzewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina","family":"Sollors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Friedmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Chin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Kirk","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfrey S.","family":"Getz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Reardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole L.","family":"Banka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Witztum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2011.07.017_bib1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis","volume":"104","author":"Glass","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.jacc.2011.07.017_bib2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.2001.tb03943.x","article-title":"Scavenger receptors, oxidized LDL, and atherosclerosis","volume":"947","author":"Boullier","year":"2001","journal-title":"Ann NY Acad Sc"},{"issue":"Suppl","key":"10.1016\/j.jacc.2011.07.017_bib3","doi-asserted-by":"crossref","first-page":"S282","DOI":"10.1194\/jlr.R800066-JLR200","article-title":"The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges","volume":"50","author":"Greaves","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacc.2011.07.017_bib4","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1172\/JCI26130","article-title":"You are right too!","volume":"115","author":"Witztum","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2011.07.017_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/cvr\/cvm093","article-title":"Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I\/II","volume":"78","author":"Kuchibhotla","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2011.07.017_bib6","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1172\/JCI24061","article-title":"Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice","volume":"115","author":"Moore","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2011.07.017_bib7","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1172\/JCI8472","article-title":"Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity","volume":"105","author":"Shaw","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2011.07.017_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1172\/JCI4533","article-title":"Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins","volume":"103","author":"Horkko","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2011.07.017_bib9","doi-asserted-by":"crossref","first-page":"9163","DOI":"10.1074\/jbc.275.13.9163","article-title":"The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein","volume":"275","author":"Boullier","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacc.2011.07.017_bib10","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0022-2275(20)30281-9","article-title":"Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein","volume":"42","author":"Gillotte-Taylor","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacc.2011.07.017_bib11","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm876","article-title":"Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL","volume":"9","author":"Binder","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2011.07.017_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2005.11.033","article-title":"Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice","volume":"189","author":"Faria-Neto","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2011.07.017_bib13","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jacc.2006.11.054","article-title":"Phosphorylcholine-targeting immunization reduces atherosclerosis","volume":"50","author":"Caligiuri","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl","key":"10.1016\/j.jacc.2011.07.017_bib14","doi-asserted-by":"crossref","first-page":"S388","DOI":"10.1194\/jlr.R800100-JLR200","article-title":"The role of innate immunity in atherogenesis","volume":"50","author":"Hartvigsen","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacc.2011.07.017_bib15","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1161\/CIRCULATIONAHA.107.757120","article-title":"Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes","volume":"117","author":"Briley-Saebo","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.07.017_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jacc.2010.09.023","article-title":"Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes","volume":"57","author":"Briley-Saebo","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2011.07.017_bib17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0009-9120(97)00049-0","article-title":"Removal of endotoxin from recombinant protein preparations","volume":"30","author":"Liu","year":"1997","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jacc.2011.07.017_bib18","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1161\/01.ATV.0000079793.58054.2E","article-title":"Genetic background selectively influences innominate artery atherosclerosis: immune system deficiency as a probe","volume":"23","author":"Reardon","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2011.07.017_bib19","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.ATV.0000258790.35810.02","article-title":"A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome","volume":"27","author":"Hartvigsen","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2011.07.017_bib20","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1172\/JCI36800","article-title":"Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans","volume":"119","author":"Chou","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2011.07.017_bib21","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1172\/JCI18730","article-title":"Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta\/delta, and gamma","volume":"114","author":"Li","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2011.07.017_bib22","doi-asserted-by":"crossref","first-page":"e6679","DOI":"10.1371\/journal.pone.0006679","article-title":"Transgene expression is associated with copy number and cytomegalovirus promoter methylation in transgenic pigs","volume":"4","author":"Kong","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2011.07.017_bib23","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/hq0801.093587","article-title":"Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo","volume":"21","author":"Shaw","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2011.07.017_bib24","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","article-title":"Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications","volume":"116","author":"Tabas","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.07.017_bib25","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/ATVBAHA.109.191940","article-title":"Dietary cholesterol plays a role in CD36-mediated atherogenesis in LDLR-knockout mice","volume":"29","author":"Kennedy","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2011.07.017_bib26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/386292a0","article-title":"A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection","volume":"386","author":"Suzuki","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2011.07.017_bib27","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI9259","article-title":"Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice","volume":"105","author":"Febbraio","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2011.07.017_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/ATVBAHA.108.176644","article-title":"Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice","volume":"29","author":"Manning-Tobin","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2011.07.017_bib29","first-page":"136","article-title":"CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima","volume":"119","author":"Park","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2011.07.017_bib30","first-page":"A299","article-title":"Increased expression of oxidation-specific epitopes and Lp(a) reflect unstable plaques in human coronary arteries","volume":"49","author":"Burke","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2011.07.017_bib31","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1161\/01.ATV.0000149378.98458.fe","article-title":"Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization","volume":"24","author":"Torzewski","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2011.07.017_bib32","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1194\/jlr.M800284-JLR200","article-title":"VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice","volume":"50","author":"VanderLaan","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacc.2011.07.017_bib33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/CIRCRESAHA.111.240515","article-title":"Effect of the oxLDL binding protein Fc-CD68 on plaque extension and vulnerability in atherosclerosis","volume":"108","author":"Zeibig","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2011.07.017_bib34","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/01.CIR.0000143162.56057.B5","article-title":"Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis","volume":"110","author":"Schiopu","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2011.07.017_bib35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"360","author":"Aiuti","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2011.07.017_bib36","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jacc.2011.07.017_bib37","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cmet.2010.09.010","article-title":"Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress","volume":"12","author":"Seimon","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.jacc.2011.07.017_bib38","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ncb0311-184","article-title":"Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress","volume":"13","author":"Tabas","year":"2011","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jacc.2011.07.017_bib39","first-page":"P385","article-title":"Identification of oxidized phospholipids and cholesteryl esters in embolic protection devices post percutaneous coronary, carotid and peripheral interventions in humans","author":"Ravandi","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2011.07.017_bib40","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1161\/01.CIR.0000130844.01174.55","article-title":"Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein","volume":"109","author":"Tsimikas","year":"2004","journal-title":"Circulation"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109711027604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109711027604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:47:50Z","timestamp":1760014070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109711027604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":40,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0735109711027604"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2011.07.017","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human Oxidation-Specific Antibodies Reduce Foam Cell Formation and Atherosclerosis Progression","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2011.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}